You are here

BIOTEK, INC.

Company Information
Address
21-C OLYMPIA AVENUE
WOBURN, MA 01801
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. SUSTAINED-RELEASE MICROCAPSULES FOR MEGALOBLASTIC ANEMIA

    Amount: $49,927.00

    THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP A BIODEGRADABLE INJECTABLE MICROCAPSULE SYSTEM FOR SUSTAINED RELEASE OF VITAMIN B12 FOR MAINTENANCE THERAPY OF PATIENTS WITH MEGALOBLASTIC ANEMIA. AFTER A S ...

    SBIRPhase I1989Department of Health and Human Services
  2. ANTIMICROBIAL WOUND DRESSING

    Amount: $480,000.00

    COMBAT WOUNDS ARE CHARACTERIZED BY A HIGH INCIDENCE OF INFECTION. TOPICAL APPLICATION OF BROAD SPECTRUM ANTIMICROBIAL AGENTS BY SUSTAINED RELEASE SYSTEM CAN PROVIDE THERAPEUTIC LEVELS FOR A PROLONGED ...

    SBIRPhase II1988Department of Defense Army
  3. DEVELOPMENT OF TRANSDERMAL ANTIHISTAMINE DELIVERY SYSTEM

    Amount: $50,000.00

    THE OVERALL OBJECTIVE OF THE PROJECT IS TO DEVELOP A TRANSDERMAL DOSAGE FORM OF THE H(1)-BLOCKER CARBINOXAMINE FOR 24-HOUR CONTROL OF ALLERGIC RHINITIS. IN PHASE I THE FEASIBILITY OF SUCH DOSAGE WILL ...

    SBIRPhase I1988Department of Health and Human Services
  4. ONE WEEK SUSTAINED RELEASE METHADONE MICROCAPSULES

    Amount: $50,000.00

    N/A

    SBIRPhase I1988Department of Health and Human Services
  5. SUSTAINED-RELEASE NALTREXONE MICROCAPSULES

    Amount: $50,000.00

    THE OBJECTIVE OF THIS PROJECT IS TO DEVELOP SUSTAINED-ACTION, INJECTABLE, BIODEGRADABLE, NALTREXONE MICROCAPSULES TO MAINTAIN PLASMA LEVELS AT 2 NG/ML FOR AT LEAST 1 MONTH. PHASE I SUPPORT IS SOUGHT F ...

    SBIRPhase I1987Department of Health and Human Services
  6. MICROENCAPSULATION OF UNSTABLE CHEMICALS FOR RODENT FEED

    Amount: $49,000.00

    THE OVERALL OBJECTIVE OF THE PROJECT IS TO DEVELOP MICROENCAPSULATION PROCEDURES AND FORMULATIONS FOR STABILIZING THE PROPERTIES OF CHEMICALS THAT ARE UNSTABLE UNDER NORMAL ENVIRONMENTAL CONDITIONS. T ...

    SBIRPhase I1987Department of Health and Human Services
  7. SUSTAINED-RELEASE FLUORIDE DENTIFRICE

    Amount: $50,000.00

    THE OVERALL OBJECTIVE OF THE 6-MONTH PROJECT IS TO DEVELOP ASUSTAINED-RELEASE FLUORIDE DENTIFRICE FORMULATION BASED ON MICROCAPSULES WITH A DURATION OF 12 TO 24 HOURS. IN PHASE I, SODIUM FLUORIDE MICR ...

    SBIRPhase I1987Department of Health and Human Services
  8. TRANSDERMAL NICOTINE-AN AID TO SMOKING CESSATION

    Amount: $50,000.00

    N/A

    SBIRPhase I1987Department of Health and Human Services
  9. SUSTAINED-ACTION NALMEFENE

    Amount: $50,000.00

    N/A

    SBIRPhase I1987Department of Health and Human Services
  10. DEVELOPMENT OF A ONCE-DAILY CONTRACEPTIVE SKIN PATCH

    Amount: $500,000.00

    THE OVERALL OBJECTIVE OF THE RESEARCH APPLICATION IS TO DEMONSTRATE THE POTENTIAL OF THE DERMAPATCH DRUG DELIVERY SYSTEM DEVELOPED BY BIOTEK FOR THE TRANSDERMAL DELIVERY OF THERAPEUTIC AGENTS. THE SPE ...

    SBIRPhase II1986Department of Health and Human Services
US Flag An Official Website of the United States Government